Cuprina Holdings Limited - יחס שווי פעילות לרווח לפני ריבית, מסים ופחת CUPR

Cuprina Holdings (Cayman) Ltd (CUPR) is developing a highly specialized complex for the therapy of chronic skin injuries, where the loyalty of Singaporean medical professionals is constrained by strict regulations. The business relies on biotherapeutic larval methods and proprietary software, creating a high switching barrier for clinics. The EV/EBITDA price trend is fixed at 0.00. Cuprina Holdings (Cayman) Ltd is implementing unique dressing materials, becoming a key medical operator in the Asian region.
פילוחי מדדים פיננסיים ומדדי שוק עבור Cuprina Holdings (Cayman) Ltd. (CUPR)

Cuprina Holdings (Cayman) Ltd (CUPR) combines in-house production with a high dependency on external CRO partners, creating a specific capital expenditure structure. The EV/EBITDA trend, accounting for debt and amortization, reflects the total enterprise value relative to operating profit before interest and taxes, allowing investors to use this chart to determine whether the asset is overvalued or if there is buying potential at low valuations.